Search Results
Oral Testimony to the FDA Advisory Committee on the Approval of tofersen
Oral Testimony by Dr. Senda Ajroud-Driss to the FDA Advisory Committee meeting on tofersen
FDA Advisory Committee to Consider Tofersen
Why FDA Decision on Tofersen Matters
Tofersen and the FDA Approval Process
FDA Approves Biogen’s Tofersen Drug for Rare Form of ALS
Tofersen (Qalsody), First FDA Approved Medication For SOD1-ALS (Amyotrophic Lateral Sclerosis)
BREAKING: FDA Approves Qalsody for ALS
March 22, 2023 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)
75th Cellular, Tissue, and Gene Therapies Advisory Committee
7 generations battling ALS: Rockford family's new hope with experimental drug
74th Cellular, Tissue, and Gene Therapies Advisory Committee
